National Institutes of Health Announce Research Grant for Tools To Advance Antibiotic Discovery

The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on developing and utilizing novel predictive assays, models and/or research tools based on penetration and efflux of small molecules to facilitate therapeutic discovery for select Gram-negative bacterial pathogens: carbapenem-resistant Enterobacteriaceae (CRE), MDR Acinetobacter and/or MDR Pseudomonas aeruginosa.

Click here to read more.

Share thisShare on FacebookTweet about this on TwitterEmail this to someone
The British Society for Antimicrobial Chemotherapy (BSAC)
© 2017 Registered Charity 1093118.

Registered as a company limited by guarantee in England & Wales No: 4443910

By using this site, you agree to using cookies.
For more details about cookies and how to disable them, see resource here >
Top